Reported Feb 12, 2020 · Terminated
Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for
Graviti Pharmaceuticals Private Limited
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Graviti Pharmaceuticals Private Limited · Survey No. 621 Isnapur Village · Medak, N/A · N/A
Is this the product you have?
Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for
3 of 3 products
| # | Product as published |
|---|---|
| 1 | Biocon Pharma Inc., Iselin, NJ 08830-3009 USA |
| 2 | Manufactured By: Graviti Pharmaceuticals Pvt. Ltd., Telangana -502307, INDIA |
| 3 | NDC 70377-027-11. |
- Lot codes and dates
Lot #: ATA318099CExp 12/2020
- Amount recalled
- 29,056 bottles
Where it was sold
- Nationwide
Why it was recalled
Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Graviti Pharmaceuticals Private Limited recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.